Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Pyrazinamide

Generic Name: Pyrazinamide

Brand Names: Rifater, Tebrazid

Drug Type: Small Molecule

Chemical Formula: C_₅H_₅N_₃O

CAS Number: 98-96-4

Unique Ingredient Identifier: 2KNI5N06TI

Overview

A pyrazine that is used therapeutically as an antitubercular agent.

Background

A pyrazine that is used therapeutically as an antitubercular agent.

Indication

For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.

Associated Conditions

Active Tuberculosis
Pulmonary Tuberculosis (TB)

Clinical Trials

Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment

Phase 3

Not yet recruiting

Posted: 2022/07/12

Sponsor:

First Affiliated Hos...

ID:NCT05454345

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Phase 2

Suspended

Posted: 2022/05/20

Sponsor:National Institute o...

ID:NCT05383742

A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Phase 4

Recruiting

Posted: 2022/04/01

Sponsor:

Beijing Chest Hospit...

ID:NCT05306223

Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

Active, not recruiting

Posted: 2021/09/16

Sponsor:

Tuberculosis Researc...

ID:NCT05047055

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Phase 2

Active, not recruiting

Posted: 2021/06/18

Sponsor:

University of Massac...

ID:NCT04930744

FDA Approved Products

PYRAZINAMIDE

Manufacturer:MARLEX PHARMACEUTICALS, INC

Route:ORAL

Strength:500 mg in 1 1

Approved: 2023/12/04

NDC:10135-735

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy